Rosalind Advisors, Inc. 13D and 13G filings for Spruce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 12:50 pm Unchanged |
2024-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 0 0.000% |
0 (Unchanged) |
Filing |
| 2024-10-23 2:26 pm Sale |
2024-09-30 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 0 0.000% |
-1,508,419 (Position Closed) |
Filing |
| 2024-04-25 6:52 pm Sale |
2024-03-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 1,508,419 3.670% |
-813,581 (-35.04%) |
Filing |
| 2024-01-30 11:06 am Purchase |
2024-01-24 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 2,322,000 5.670% |
2,322,000 (New Position) |
Filing |